A novel drug "copper acetylacetonate" loaded in folic acid-tagged chitosan nanoparticle for efficient cancer cell targeting

Journal of Drug Targeting

Volumn 22, Issue 1, 2014, Pages 23-33

  Pramanik, Arindam ^a   Laha, Dipranjan ^a   Pramanik, Panchanan ^b   Karmakar, Parimal ^a  

^a JADAVPUR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cancer targeting; Chitosan; Folate; Nanoparticles

Indexed keywords

ACETYLACETONATE COPPER; CHITOSAN; COPPER DERIVATIVE; FOLIC ACID; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CHITOSAN; FOLIC ACID; GLUTATHIONE; HEK293 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYDROXYBUTYRATES; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NANOPARTICLES; NIH 3T3 CELLS; PENTANONES; REACTIVE OXYGEN SPECIES; SOLUBILITY;

EID: 84890394391     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.832768     Document Type: Article

References (49)

1. Rochow E, Hurd D, Lewis P. Khimiia metalloorganicheskikh soedinenii. The Great Soviet Encyclopedia, 1970-1979. Russia: Sovetskaya entsiklopediya; 1963.
2. Guo Y, Zhang J, Yang L, et al. Syntheses of amorphous and crystalline cupric sulfide nanoparticles and study on the specific activities on different cells. Chem Commun 2010;46:3493-5.
3. Sadzuka Y, Nagamine M, Toyooka T, et al. Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int J Pharm 2012;432:42-9.
4. Singh KV, Bhura DK, Nandamuri G, et al. Nanoparticle-enhanced sensitivity of a nanogap-interdigitated electrode array impedimetric biosensor. Langmuir 2011;27:13931-9.
5. Hajdu I, Bodnár M, Trencsényi G, et al. Cancer cell targeting and imaging with biopolymer-based nanodevices. Int J Pharm 2013; 441:234-41.
6. Chen H, Li B, Wang C, et al. Characterization of a fluorescence probe based on gold nanoclusters for cell and animal imaging. Nanotechnology 2013;24:055704-13.
7. Alex SM, Rekha MR, Sharma CP. Spermine grafted galactosylated chitosan for improved nanoparticle mediated gene delivery. Int J Pharm 2011;410:125-37.
8. Ye Y, Xu Y, Liang W, et al. DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells. J Drug Target 2013;21:474-86.
9. Patel SK, Gajbhiye V, Jain NK. Synthesis, characterization and brain targeting potential of paclitaxel loaded thiamine-PPI nanoconjugates. J Drug Target 2012;20:841-9.
10. Gelperina S, Kisich K, Iseman MD, et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005;172:1487-90.
11. Moddaresi M, Brown MB, Zhaoa Y, et al. The role of vehicle-nanoparticle interactions in topical drug delivery. Int J Pharm 2010; 400:176-82.
12. Deng Z, Xu S, Li S. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications. Int J Pharm 2008;351:236-43.
13. Sultana S, Khan MR, Kumar M, et al. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. J Drug Target 2013;21:107-25.
14. Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci 2011;36: 887-913.
15. Sinha VR, Singla AK,Wadhawan S, et al. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004;274:1-33.
16. Jayakumar R, Chennazhi KP, Muzzarelli RAA, et al. Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydr Polym 2010;79:1-8.
17. Shena JM, Tanga WJ, Zhanga XL, et al. A novel carboxymethyl chitosan-based folate/Fe3O4/CdTe nanoparticle for targeted drug delivery and cell imaging. Carbohydr Polym 2012;88:239-49.
18. Chakravarthi SS, Robinson DH. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Int J Pharm 2011; 409:111-20.
19. Byrne JD, Betancourt T, Peppas LB. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008;60:1615-26.
20. Mohapatra S, Mallick SK, Maiti TK, et al. Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells. Nanotechnology 2007;18:385102-11.
21. Franklin WA, Waintrub M, Edwards D, et al. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Cancer Suppl 1994;8:89-95.
22. Niu R, Zhao P, Wang H, et al. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes. J Drug Target 2011;19:373-81.
23. Mukherjee SG, Claonadh NO, Casey A, et al. Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines. Toxicol In Vitro 2012;26:238-51.
24. Hackenberg S, Scherzed A, Technau A, et al. Cytotoxic, genotoxic and pro-inflammatory effects of zinc oxide nanoparticles in human nasal mucosa cells in vitro. Toxicol In Vitro 2011;25: 657-63.
25. Laha D, Bhattacharya D, Pramanik A, et al. Evaluation of copper iodide and copper phosphate nanoparticles for their potential cytotoxic effect. Toxicol Res 2012;1:131-6.
26. Ramos JF, Webster TJ. Cytotoxicity of selenium nanoparticles in rat dermal fibroblasts. Int J Nanomedicine 2012;7:3907-14.
27. Chen J, Dong X, Zhao J, et al. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol 2009;29:330-7.
28. Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009;35:32-46.
29. Ahamed M, Siddiqui MA, Akhtar MJ, et al. Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells. Biochem Biophys Res Commun 2010;396:578-83.
30. Pramanik A, Laha D, Bhattacharya D, et al. A novel study of antibacterial activity of copper iodide nanoparticle mediated by DNA and membrane damage. Colloids Surf B Biointerfaces 2012; 96:50-5.
31. Shi L, Tang C, Yin C. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials 2012;33:7594-604.
32. Giambra V, Jenkins CR, Wang H, et al. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-and reactive oxygen species. Nat Med 2012;18:1693-8.
33. Liu QB, Liu LL, Lu YM, et al. The induction of reactive oxygen species and loss of mitochondrial Omi/HtrA2 is associated with S-nitrosoglutathione- induced apoptosis in human endothelial cells. Toxicol Appl Pharmacol 2010;244:374-84.
34. Shamsi FA, Boulton M. Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci 2001;42:3041-6.
35. Vassault SA. Lactate dehydrogenase. In: Bergemeyer H, ed. Methods of enzyme analysis. Weinheim: Verlag Chemie; 1983:118-26.
36. Cerella C, Scherer C, Cristofanon S, et al. Cell cycle arrest in early mitosis and induction of caspase-dependent apoptosis in U937 cells by diallyltetrasulfide (Al2S4). Apoptosis 2009;14: 641-54.
37. Li Q, Kobayashi M, Kawada T. Mechanism of ziraminduced apoptosis in human T lymphocytes. Arch Toxicol 2012; 86:615-23.
38. Chaitanya GV, Babu PP. Activation of calpain, cathepsin-b and caspase-3 during transient focal cerebral ischemia in rat model. Neurochem Res 2008;33:2178-86.
39. Chen XG, Park HJ. Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions. Carbohydr Polym 2003;53:355-9.
40. Hu FQ, Li YH, Yuan H, et al. Novel self-aggregates of chitosan oligosaccharide grafted stearic acid: preparation, characterization and protein association. Pharmazie 2006;6:194-8.
41. Verma P, Liu S, Chen YY, et al. Size-tunable nanoparticles composed of dextran-b-poly(D,L-lactide) for drug delivery applications. Nano Res 2012;5:49-61.
42. Avdeev VI, Zakharov II. Calculation of the ultraviolet and visible spectra of copper acetylacetonate. Theor Exp Chem 1966;2:451-5.
43. Appierto V, Tiberio P, Villani MG, et al. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS dependent mechanism involving ER stress and JNK activation. Carcinogenesis 2009;30:824-31.
44. Qian Y, Zheng Y, Abraham L, et al. Differential profiles of copperinduced ROS generation in human neuroblastoma and astrocytoma cells. Mol Brain Res 2005;134:323-32.
45. Engelmann J, Volk J, Leyhausen G, et al. ROS formation and glutathione levels in human oral fibroblasts exposed to TEGDMA and camphorquinone. J Biomed Mater Res B Appl Biomater 2005; 75:272-6.
46. Droge W. Free radicals in the physiological control of cell function. Phys Rev 2002;82:47-95.
47. Decker T, Matthes MLL. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988;115:61-9.
48. Vitali P, Scadden ADJ. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat Struct Mol Biol 2010;17:1043-50.
49. Wang Y, Cao X, Guo R, et al. Targeted delivery of doxorubicin into cancer cells using a folic acid-dendrimer conjugate. Polym Chem 2011;2:1754-60.